A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy.

Angela C HirbeJack JenningsNael SaadJoseph D GiardinaYu TaoJingqin LuoShellie BerryJacqui ToeniskoetterBrian A Van Tine

Published in: The oncologist (2018)

Our data are the first prospective study to suggest that ablation therapy in selected patients who are stable on chemotherapy can provide a significant progression-free interval off therapy and warrants further study in a randomized trial.

Keyphrases

phase ii study
locally advanced
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rectal cancer
open label
prognostic factors
peritoneal dialysis
electronic health record
stem cells
patient reported outcomes
machine learning
atrial fibrillation
cell therapy
deep learning